#10: A Breakthrough in Alzheimer's Disease Treatment: The Approval of Lecanemab

Good afternoon. Welcome to another episode of Medical Narratives, the podcast where we explore best practices, groundbreaking medical research and advancements in medicine. I'm Dr. Michael Gordon, the host of the Medical Narrative Podcast. In today's episode, we review the news that Lecanemab has received approval as a treatment for early Alzheimer's disease from the U.S. Food and Drug Administration, the FDA.

A potential much needed good news in Alzheimer's treatment. Our guest today is Dr. Sharon Cohen. Dr. Cohen is a behavioural neurologist and the medical director of the Toronto Memory Program, a community based medical facility which she established in 1996 for the purpose of the advancing diagnosis and treatment for individuals with Alzheimer's disease and related disorders.

Please note, that to access this episode in full instead of the teaser available just below you would need to login.


6 applauses

Dr. Michael Gordon recently retired after a fulfilling career as a geriatrician that spanned 56 years, 44 of which he spent working at the Baycrest Center in Toronto. He is Emeritus Professor of Medicine at the University of Toronto. Dr. Gordon is a recognized ethicist and a thought leader on all topics of care of the elderly and end-of-life decisions. Currently, Dr. Gordon provides part-time professional medical consulting mainly in the domain of cognition and memory loss.